Regeneron Pharmaceuticals
This role offers an opportunity to lead the strategy, development, and lifecycle management of companion diagnostic solutions across diverse therapeutic areas. It involves cross-functional collaboration, regulatory compliance, and partner management to deliver diagnostic assays that support drug development and clinical decision-making.
Headquarters
Tarrytown, New York, United States
Company Size
10001+ employees
Founded
1988
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Quadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN
4 hours ago
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
6 hours ago
Will Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative?
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
Regeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)
1 day ago
Biomarker Clinical Assay Lead Manager
Pfizer
Executive Director, Companion Diagnostics
MSD
Associate Director, Companion Diagnostics
Revolution Medicines
Distinguished Scientist, Companion Diagnostics
MSD
Director, Regulatory Affairs Companion Diagnostics
Revolution Medicines
Associate Director, Companion Diagnostics
Genmab